Skip to main content
logo
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.41
+0.01 (0.19%)
Jul 29, 2026, 11:09 AM EDT - Market open

Verrica Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
37.1635.587.575.129.0312
Revenue Growth
417.64%370.22%47.66%-43.27%-24.73%-
Gross Profit
33.2732.144.834.388.3112
Operating Income
3.14-12.19-65.92-65.76-21.3-30.91
Net Income
0.2-17.89-76.58-67-24.49-35.08
Earnings Per Share
-1.03-1.68-14.78-14.80-7.20-13.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
20.630.1546.3369.5534.2770.35
Total Debt
1.441.6345.9445.511.5343.41
Net Cash (Debt)
19.1628.520.3924.0432.7526.95
Net Cash Growth
-7211.79%-98.38%-26.60%21.53%-4.67%
Net Cash Per Share
1.412.680.085.309.599.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.63-17.63-60.93-38.58-18.65-27.58
Capital Expenditures
---0.03-0.36-0.3-0.88
Free Cash Flow
-17.63-17.63-60.95-38.94-18.95-28.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
89.52%90.33%63.79%85.44%91.97%100.00%
Operating Margin
8.44%-34.25%-871.25%-1283.35%-235.78%-257.57%
Pretax Margin
1.65%-50.27%-1012.15%-1307.47%-271.11%-292.33%
Profit Margin
0.55%-50.27%-1012.15%-1307.47%-271.11%-292.33%
FCF Margin
0.00%-49.55%-805.63%-759.93%-209.83%-237.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.474.018.4960.5912.5121.01